| Primary |
| Iron Overload |
30.1% |
| Myelodysplastic Syndrome |
21.7% |
| Sickle Cell Anaemia |
12.6% |
| Iron Metabolism Disorder |
3.7% |
| Aplastic Anaemia |
3.3% |
| Haemochromatosis |
3.0% |
| Prophylaxis |
2.6% |
| Neoplasm |
2.5% |
| Blood Iron Increased |
2.5% |
| Thalassaemia |
2.3% |
| Pain |
2.2% |
| Serum Ferritin Increased |
1.8% |
| Hypertension |
1.8% |
| Anaemia |
1.7% |
| Thalassaemia Beta |
1.7% |
| Haemosiderosis |
1.7% |
| Acute Myeloid Leukaemia |
1.5% |
| Myelofibrosis |
1.5% |
| Blood Disorder |
0.8% |
| Lymphatic Disorder |
0.8% |
|
| Death |
41.6% |
| Sickle Cell Anaemia With Crisis |
10.9% |
| Vomiting |
5.8% |
| Pneumonia |
4.7% |
| Diarrhoea |
4.4% |
| Pyrexia |
3.2% |
| Serum Ferritin Increased |
2.8% |
| White Blood Cell Count Increased |
2.6% |
| Weight Decreased |
2.6% |
| Sepsis |
2.4% |
| White Blood Cell Count Decreased |
2.4% |
| Renal Failure |
2.4% |
| Rash |
2.1% |
| Nausea |
2.0% |
| Malaise |
1.9% |
| Pain |
1.9% |
| Renal Disorder |
1.7% |
| Thrombocytopenia |
1.6% |
| Neoplasm Malignant |
1.6% |
| Urinary Tract Infection |
1.5% |
|
| Secondary |
| Iron Overload |
30.6% |
| Myelodysplastic Syndrome |
23.5% |
| Sickle Cell Anaemia |
7.2% |
| Prophylaxis |
6.8% |
| Aplastic Anaemia |
4.3% |
| Serum Ferritin Increased |
2.6% |
| Blood Iron Increased |
2.4% |
| Iron Metabolism Disorder |
2.4% |
| Pain |
2.3% |
| Hypertension |
2.3% |
| Haemochromatosis |
2.1% |
| Thalassaemia |
1.9% |
| Thalassaemia Beta |
1.8% |
| Anaemia |
1.7% |
| Haemosiderosis |
1.7% |
| Myelofibrosis |
1.7% |
| Acute Myeloid Leukaemia |
1.6% |
| Neoplasm |
1.2% |
| Lymphatic Disorder |
1.1% |
| Blood Disorder |
1.0% |
|
| Vomiting |
14.0% |
| Death |
9.9% |
| Weight Decreased |
7.9% |
| Diarrhoea |
6.3% |
| Sickle Cell Anaemia With Crisis |
6.0% |
| Serum Ferritin Increased |
5.7% |
| White Blood Cell Count Increased |
5.6% |
| White Blood Cell Count Decreased |
4.9% |
| Pneumonia |
4.8% |
| Pyrexia |
4.7% |
| Sepsis |
4.2% |
| Nausea |
3.8% |
| Vision Blurred |
3.8% |
| Rash |
3.3% |
| Urinary Tract Infection |
3.1% |
| Renal Disorder |
2.5% |
| Urticaria |
2.4% |
| Blood Creatinine Increased |
2.4% |
| Malaise |
2.4% |
| Thrombocytopenia |
2.4% |
|
| Concomitant |
| Product Used For Unknown Indication |
25.1% |
| Drug Use For Unknown Indication |
23.3% |
| Paroxysmal Nocturnal Haemoglobinuria |
11.6% |
| Myelodysplastic Syndrome |
10.2% |
| Iron Overload |
4.5% |
| Prophylaxis |
4.3% |
| Constipation |
2.5% |
| Hypertension |
2.2% |
| Myelofibrosis |
2.1% |
| Acute Myeloid Leukaemia |
1.8% |
| Aplastic Anaemia |
1.8% |
| Pain |
1.6% |
| Insomnia |
1.5% |
| Haemochromatosis |
1.3% |
| Multiple Myeloma |
1.3% |
| Cancer Pain |
1.2% |
| Anaemia |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
| Pulmonary Arterial Hypertension |
0.9% |
| Osteoporosis |
0.9% |
|
| Pneumonia |
8.6% |
| Thrombocytopenia |
8.3% |
| Pyrexia |
7.8% |
| Vomiting |
7.8% |
| White Blood Cell Count Decreased |
7.8% |
| Sepsis |
7.2% |
| Platelet Count Decreased |
6.6% |
| Death |
6.3% |
| Haemoglobin Decreased |
4.9% |
| Pancytopenia |
4.9% |
| Fatigue |
3.7% |
| Septic Shock |
3.7% |
| Myelodysplastic Syndrome |
3.4% |
| Urinary Tract Infection |
3.4% |
| Serum Ferritin Increased |
3.2% |
| Rash |
2.9% |
| Anaemia |
2.6% |
| White Blood Cell Count Increased |
2.6% |
| Neutropenia |
2.3% |
| Febrile Neutropenia |
2.0% |
|
| Interacting |
| Product Used For Unknown Indication |
22.2% |
| Iron Overload |
9.5% |
| Thrombosis Prophylaxis |
9.5% |
| Myelodysplastic Syndrome |
7.9% |
| Thalassaemia Beta |
6.3% |
| Aplastic Anaemia |
4.8% |
| Myelofibrosis |
4.8% |
| Platelet Count Increased |
4.8% |
| Prophylaxis Against Gastrointestinal Ulcer |
4.8% |
| Tachycardia |
4.8% |
| Hepatitis C |
3.2% |
| Immunosuppression |
3.2% |
| Sickle Cell Anaemia |
3.2% |
| Antifungal Prophylaxis |
1.6% |
| Arthropathy |
1.6% |
| Aspergillus Infection |
1.6% |
| Bronchitis |
1.6% |
| Chelation Therapy |
1.6% |
| Diabetes Mellitus |
1.6% |
| Haemosiderosis |
1.6% |
|
| Renal Failure |
13.0% |
| Serum Ferritin Increased |
13.0% |
| Weight Increased |
13.0% |
| Liver Function Test Abnormal |
8.7% |
| Proteinuria |
8.7% |
| Transaminases Increased |
8.7% |
| Blood Creatinine Increased |
4.3% |
| Fatigue |
4.3% |
| Hepatitis Toxic |
4.3% |
| Maternal Exposure During Pregnancy |
4.3% |
| Medication Error |
4.3% |
| Oedema Peripheral |
4.3% |
| Serum Ferritin Decreased |
4.3% |
| Vomiting |
4.3% |
|
